Tirzepatide for weight loss According to Eli Lilly, the manufacturer of Zepbound (tirzepatide weight loss drug), people taking Zepbound 15 mg lost up to 48 pounds, or a 21% weight loss
Among small-molecule oral GLP-1 candidates, orforglipron is the most clinically advanced and the only one to have completed multiple Phase 3 trials with positive results
71% say they eat less and according to Circana, they remain high-value consumers because they came from a higher spending baseline, and this is not a shrinking consumer, it is a more intentional one, with smaller baskets, but higher standards per unit
Medications that impact saliva flow or introduce acid to the oral cavity have long been known to increase dental risk
Rapid weight loss during the first trimesterif pregnancy occurs while taking GLP-1 therapycould theoretically reduce nutrient availability to a developing fetus, which is why timing and medical oversight matter